IL140353A0 - Pharmaceutical formulations for aerosols with two or more active substances - Google Patents

Pharmaceutical formulations for aerosols with two or more active substances

Info

Publication number
IL140353A0
IL140353A0 IL14035399A IL14035399A IL140353A0 IL 140353 A0 IL140353 A0 IL 140353A0 IL 14035399 A IL14035399 A IL 14035399A IL 14035399 A IL14035399 A IL 14035399A IL 140353 A0 IL140353 A0 IL 140353A0
Authority
IL
Israel
Prior art keywords
aerosols
active substances
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
IL14035399A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26046888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL140353(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1998127178 external-priority patent/DE19827178A1/de
Priority claimed from DE1998142963 external-priority patent/DE19842963A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL140353A0 publication Critical patent/IL140353A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14035399A 1998-06-18 1999-06-08 Pharmaceutical formulations for aerosols with two or more active substances IL140353A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998127178 DE19827178A1 (de) 1998-06-18 1998-06-18 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
DE1998142963 DE19842963A1 (de) 1998-09-19 1998-09-19 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
PCT/US1999/012785 WO1999065464A1 (en) 1998-06-18 1999-06-08 Pharmaceutical formulations for aerosols with two or more active substances

Publications (1)

Publication Number Publication Date
IL140353A0 true IL140353A0 (en) 2002-02-10

Family

ID=26046888

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14035399A IL140353A0 (en) 1998-06-18 1999-06-08 Pharmaceutical formulations for aerosols with two or more active substances
IL140353A IL140353A (en) 1998-06-18 2000-12-15 Pharmaceutical formulations for aerosols with two or more active substances

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL140353A IL140353A (en) 1998-06-18 2000-12-15 Pharmaceutical formulations for aerosols with two or more active substances

Country Status (32)

Country Link
EP (1) EP1087750B1 (de)
JP (1) JP2003522102A (de)
KR (1) KR100600423B1 (de)
CN (1) CN1161104C (de)
AR (1) AR019690A1 (de)
AT (1) ATE253896T1 (de)
AU (1) AU759222B2 (de)
BG (1) BG65252B1 (de)
BR (1) BR9911351A (de)
CA (1) CA2335065C (de)
CO (1) CO5070580A1 (de)
CZ (1) CZ300910B6 (de)
DE (1) DE69912781T2 (de)
DK (1) DK1087750T3 (de)
EE (1) EE04450B1 (de)
ES (1) ES2211108T3 (de)
HR (1) HRP20000867B1 (de)
HU (1) HU229064B1 (de)
ID (1) ID27554A (de)
IL (2) IL140353A0 (de)
ME (1) ME00838B (de)
MY (1) MY121073A (de)
NO (1) NO329416B1 (de)
NZ (1) NZ509418A (de)
PL (1) PL193695B1 (de)
PT (1) PT1087750E (de)
RS (1) RS49977B (de)
RU (1) RU2218152C2 (de)
SK (1) SK284756B6 (de)
TR (1) TR200003721T2 (de)
TW (1) TW528606B (de)
WO (1) WO1999065464A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
EP1143930B8 (de) 1999-09-11 2008-03-19 Glaxo Group Limited Fluticasonpropionat arzneizubereitung
WO2001037805A1 (en) * 1999-11-23 2001-05-31 Glaxo Group Limited Pharmaceutical formulations of salmeterol
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
AU2000250701B2 (en) 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE60209511T2 (de) 2001-09-18 2006-10-05 Nycomed Danmark Aps Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
EP1915985A1 (de) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulierung für einen Dosierinhalator mit Hydrofluoralkanen als Treibstoffen
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9308199B2 (en) * 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
EP1595531A1 (de) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stabile Arzneimittellösung für Druckdosierinhalatoren
WO2006101882A2 (en) * 2005-03-16 2006-09-28 Honeywell International Inc. Medicament delivery formulations, devices and methods
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8061350B2 (en) 2006-06-02 2011-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process and device for dosing pharmaceutical agents
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
RU2356537C2 (ru) * 2007-07-25 2009-05-27 Закрытое Акционерное Общество (ЗАО) "Пульмомед" Фармацевтический состав дозированных аэрозолей, содержащий противоастматические лекарственные средства в виде суспензий, растворов, эмульсий, растворов и эмульсий
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
WO2010105776A1 (en) 2009-03-17 2010-09-23 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
BR112012012475B1 (pt) 2009-11-25 2020-03-03 Boehringer Ingelheim International Gmbh Nebulizador
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
EP3020393B1 (de) 2009-12-16 2020-10-07 3M Innovative Properties Company Formulierungen und verfahren zur steuerung der mdi-partikelgrössenfreisetzung
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
CN116036425A (zh) 2014-05-07 2023-05-02 勃林格殷格翰国际有限公司 喷雾器、指示器装置及容器
IL247927B (en) 2014-05-07 2022-09-01 Boehringer Ingelheim Int Container, a device that turns a liquid into a fine spray and use
WO2020152548A1 (en) * 2019-01-24 2020-07-30 Glenmark Pharmaceuticals Limited Stable aerosol inhalation compositions of formoterol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
ATE177941T1 (de) * 1992-12-09 1999-04-15 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物

Also Published As

Publication number Publication date
CN1307470A (zh) 2001-08-08
KR100600423B1 (ko) 2006-07-13
NO20006318L (no) 2001-01-30
BG105033A (bg) 2001-09-28
DK1087750T3 (da) 2004-01-26
EP1087750B1 (de) 2003-11-12
HUP0104734A3 (en) 2003-05-28
HUP0104734A2 (hu) 2002-05-29
CA2335065C (en) 2008-06-03
PT1087750E (pt) 2004-02-27
KR20010072621A (ko) 2001-07-31
CZ20004750A3 (en) 2001-05-16
RS49977B (sr) 2008-09-29
EE200000759A (et) 2002-04-15
WO1999065464A1 (en) 1999-12-23
HU229064B1 (en) 2013-07-29
ID27554A (id) 2001-04-12
MY121073A (en) 2005-12-30
JP2003522102A (ja) 2003-07-22
CA2335065A1 (en) 1999-12-23
ATE253896T1 (de) 2003-11-15
NZ509418A (en) 2003-06-30
PL193695B1 (pl) 2007-03-30
TW528606B (en) 2003-04-21
NO20006318D0 (no) 2000-12-12
BG65252B1 (bg) 2007-10-31
HK1037974A1 (en) 2002-03-01
CZ300910B6 (cs) 2009-09-09
BR9911351A (pt) 2001-03-13
EP1087750A1 (de) 2001-04-04
DE69912781T2 (de) 2004-10-21
PL345685A1 (en) 2002-01-02
SK284756B6 (sk) 2005-11-03
AU4552199A (en) 2000-01-05
CO5070580A1 (es) 2001-08-28
TR200003721T2 (tr) 2001-06-21
ES2211108T3 (es) 2004-07-01
IL140353A (en) 2006-09-05
HRP20000867B1 (en) 2010-10-31
AR019690A1 (es) 2002-03-13
DE69912781D1 (de) 2003-12-18
NO329416B1 (no) 2010-10-18
SK19392000A3 (sk) 2001-07-10
EE04450B1 (et) 2005-04-15
ME00838B (me) 2008-09-29
YU80000A (sh) 2003-04-30
CN1161104C (zh) 2004-08-11
AU759222B2 (en) 2003-04-10
HRP20000867A2 (en) 2001-10-31
RU2218152C2 (ru) 2003-12-10

Similar Documents

Publication Publication Date Title
HUP0104734A3 (en) Pharmaceutical formulations for aerosols with two or more active substances
SG79255A1 (en) Pharmaceutical formulations
PL343491A1 (en) Pharmaceutical aerosol formulation
EG23910A (en) Pharmaceutical formulations containing voriconazole
IL147756A0 (en) Preserved pharmaceutical formulations
GB9815532D0 (en) Pharmaceutical suspension formulation
GB9818927D0 (en) Pharmaceutical formulation
GB9924992D0 (en) Pharmaceutical aerosol formulations
GB9817470D0 (en) Pharmaceutical formulation
GB9822333D0 (en) Pharmaceutical formulation
SI1087750T1 (en) Pharmaceutical formulations for aerosols with two or more active substances
ZA994697B (en) Pharmaceutical formulation.
GB9802617D0 (en) Pharmaceutical formulation
GB9826392D0 (en) Pharmaceutical formulations
GB9828205D0 (en) Pharmaceutical formulations
GB9805931D0 (en) Pharmaceutical formulations
GB9807556D0 (en) Pharmaceutical formulations
GB9813452D0 (en) Pharmaceutical formulations
GB9816558D0 (en) Pharmaceutical formulations
GB9817429D0 (en) Pharmaceutical formulations
GB9820837D0 (en) Pharmaceutical formulations
GB9823192D0 (en) Pharmaceutical formulations
GB9825117D0 (en) Pharmaceutical formulations
GB9808152D0 (en) Pharmaceutical aerosol formulation
GB9814709D0 (en) Pharmaceutical aerosol formulation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed